Piedmont Lithium Reports Q2 2025 Results
-
Piedmont recorded shipments of approximately 20,200 dmt of spodumene concentrate and recorded revenue of$11.9 million in Q2’25 - NAL produced 58,533 dmt and recorded 93% mill utilization and 73% lithium recovery in Q2’25
-
Piedmont had$56.1 million in cash and cash equivalents as ofJune 30, 2025 -
Piedmont adjourned its Special Meeting of Stockholders related to the proposed merger with toSayona Mining August 11, 2025 to allow additional time for shareholders to vote
Piedmont shipped approximately 20,200 dry metric tons (“dmt”) of spodumene concentrate (~5.3% Li2O) and recognized
NAL achieved a new quarterly production record of 58,533 dmt of spodumene concentrate in Q2’25, with lithium recovery averaging 73% and mill utilization of 93% – both representing new performance records since the restart of operations in 2023. Unit operating costs improved to
At our joint venture
As of
With respect to the proposed merger with
“NAL continued to demonstrate strong operational performance in the second quarter amidst a challenging lithium market,” said
1 The timing of shipments is subject to shipping logistics, port and weather conditions, and customer requirements. |
2 See Sayona Mining Quarterly Activities Report filed with the ASX on |
Proposed Merger of
Piedmont convened a Special Meeting of Stockholders (the “Special Meeting”) on
The Company adjourned the Special Meeting until
Sayona also held an Extraordinary General Meeting (the “Sayona EGM”) for Sayona shareholders to vote on the Merger on
Second Quarter 2025 Financial Highlights
All references to dmt in this release relate to spodumene concentrate.
|
|
Units |
|
Q2’25 |
|
Q1’25 |
|
Q2’24 |
|||
Sales |
|
|
|
|
|
|
|
||||
|
Concentrate shipped |
dmt thousands |
|
20.2 |
|
|
27.0 |
|
|
14.0 |
|
|
Revenue |
$ millions |
|
11.9 |
|
|
20.0 |
|
|
13.2 |
|
|
Realized price(1) |
$/dmt |
|
587 |
|
|
741 |
|
|
945 |
|
|
Li2O content(2) |
% |
|
5.3 |
|
|
5.4 |
|
|
5.5 |
|
|
Realized cost of sales(3) |
$/dmt |
|
668 |
|
|
736 |
|
|
900 |
|
|
|
|
|
|
|
|
|
|
|||
Profitability |
|
|
|
|
|
|
|
||||
|
Gross profit |
$ millions |
|
(1.6 |
) |
|
0.1 |
|
|
0.6 |
|
|
Gross profit margin |
% |
|
(13.8 |
) |
|
0.7 |
|
|
4.7 |
|
|
Net loss |
$ millions |
|
(9.7 |
) |
|
(15.6 |
) |
|
(13.3 |
) |
|
Diluted EPS |
$ |
|
(0.44 |
) |
|
(0.71 |
) |
|
(0.69 |
) |
|
Adjusted net loss(4) |
$ millions |
|
(7.7 |
) |
|
(10.1 |
) |
|
(12.7 |
) |
|
Adjusted diluted EPS(4) |
$ |
|
(0.35 |
) |
|
(0.46 |
) |
|
(0.65 |
) |
|
Adjusted EBITDA(4) |
$ millions |
|
(7.7 |
) |
|
(10.1 |
) |
|
(13.2 |
) |
|
|
|
|
|
|
|
|
|
|||
Cash |
|
|
|
|
|
|
|
||||
|
Cash and cash equivalents(5) |
$ millions |
|
56.1 |
|
|
65.4 |
|
|
59.0 |
|
____________________________________________ |
(1) Realized price is the average estimated price, net of certain distribution and other fees, which includes reference pricing data up to the respective period end and is subject to final adjustment. The final adjusted price may be higher or lower than the estimated average realized price based on future price movements. |
(2) Weighted average Li2O content for shipments made during the respective period. |
(3) Realized cost of sales is the average cost of sales including Piedmont’s offtake pricing agreement with |
(4) See non-GAAP Financial Measures at the end of this release for a reconciliation of non-GAAP measures. |
(5) Cash and cash equivalents are reported as of the end of the period. |
Second Quarter and Recent Business Highlights
-
Shipped approximately 20,200 dmt (~5.3% Li2O) of spodumene concentrate from NAL to customers in Q2’25 and recognized
$11.9 million in revenue with an average realized sales price of$587 per dmt. On an SC6 equivalent basis, our realized price per metric ton was$668 . -
Piedmont remains committed to pursuing the proposed merger withSayona Mining and adjourned the Special Meeting onJuly 31, 2025 toAugust 11, 2025 to allow stockholders additional time to vote their shares. At the original time of the meeting, 97.86% of the votes cast were in favor of the transaction with 41.52% of the common stock outstanding and entitled to vote represented. For the merger proposal to pass,Piedmont requires a quorum of more than 50% of the shares of common stock outstanding to vote in favor. -
In
April 2025 ,Piedmont announced key regulatory approvals for the merger were received inthe United States andCanada . -
In
April 2025 ,Piedmont announced the signing of a revised merger agreement with Sayona which incorporated, among other things, an updated exchange ratio to incorporate the terms of a proposed reverse stock split to be undertaken by Sayona as part of the merger, subject to Sayona shareholder approval.
North American Lithium (
-
In Q2’25, NAL achieved quarterly production of 58,533 dmt and shipped approximately 67,000 dmt, with approximately 20,200 dmt sold to
Piedmont . -
Production increased approximately 35% compared to the prior quarter and saw the benefit from new quarterly records for lithium recoveries (73%) and mill utilization (93%).
-
In
April 2025 , the final results from the 2024 NAL drilling program were released. The results reinforce the potential for a future expansion at NAL and will be incorporated into an updated Mineral Resource Estimate, which is expected to be released in the coming weeks. -
Concentrate shipped by
Piedmont and produced and shipped by NAL:
|
|
Share |
|
Units |
|
Q2’25 |
|
Q1’25 |
|
Q2’24 |
|
|
|
|
|
|
|
|
|
|
|
|
Concentrate shipped |
100% |
|
dmt thousands |
|
20.2 |
|
27.0 |
|
14.0 |
|
|
|
|
|
|
|
|
|
|
|
North American Lithium |
|
|
|
|
|
|
|
|
|
|
|
Concentrate produced |
100%(1) |
|
dmt thousands |
|
58.5 |
|
43.3 |
|
49.7 |
|
Concentrate shipped |
100%(2) |
|
dmt thousands |
|
67.0 |
|
27.0 |
|
27.7 |
____________________________________________ |
(1) Concentrate produced represents 100% of NAL’s production. |
(2) Concentrate shipped represents 100% of NAL’s shipments, inclusive of shipments to Piedmont. |
Note: The table above reports quarterly and year-to-date information in accordance with Piedmont’s fiscal year reporting, which is on a calendar-year basis. Concentrate produced and concentrate shipped (above) are reported in the periods in which activities occurred. For financial statement purposes, Piedmont reports income (loss) from its 25% ownership in Sayona Quebec, which includes NAL, on a one-quarter lag. |
-
In
June 2025 , our joint venture partnerAtlantic Lithium announced changes to its corporate leadership team and other initiatives focused on cost-cutting. As part of the initiatives, day-to-day management of Atlantic Lithium was consolidated under Chief Executive OfficerKeith Mueller . -
In
July 2025 , Atlantic Lithium provided an update related to ongoing negotiations related to the Mining Lease for theEwoyaa Lithium Project . The update noted that Ghana’s Minister of Lands and Natural Resources confirmed that revised terms of the Mining Lease were being negotiated in light of the lithium price environment.
Carolina Lithium (
-
Piedmont continues to pursue an air permit application currently under review by North Carolina’s
Division of Air Quality , which would allow for up to 60,000 tons per year of lithium hydroxide production at Carolina Lithium, and a North Carolina General Stormwater permit.
2025 Outlook
|
Units |
|
H1’25 |
|
Q3’25 |
|
Q4’25 |
|
FY25 |
Shipments |
dmt thousands |
|
47 |
|
23 — 27 |
|
43 — 50 |
|
113 — 125 |
Capital expenditures |
$ millions |
|
2 |
|
0 — 1 |
|
0 — 2 |
|
3 — 5 |
Investments in and advances to affiliates |
$ millions |
|
7 |
|
3 — 5 |
|
3 — 6 |
|
13 — 18 |
Under our offtake agreement with Sayona Quebec,
We expect to spend less than
Safety and Sustainability
The Company continued policy development and training to support the long-term objective of establishing a robust safety and health management system. Employee engagement in safety events remained strong and identification and reporting of hazards, unsafe acts, conditions, and safety observations, and near misses continued to improve.
About
Cautionary Note to U.S. Investors
Piedmont’s public disclosures are governed by the
The statements in the link below were prepared by, and made by, NAL. The following disclosures are not statements of
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of or as described in securities legislation in
|
||||||||||||||||
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
Revenue |
|
$ |
11,857 |
|
|
$ |
13,227 |
|
|
$ |
31,853 |
|
|
$ |
26,628 |
|
Costs of sales |
|
|
13,489 |
|
|
|
12,601 |
|
|
|
33,351 |
|
|
|
25,311 |
|
Gross profit (loss) |
|
|
(1,632 |
) |
|
|
626 |
|
|
|
(1,498 |
) |
|
|
1,317 |
|
Exploration costs |
|
|
— |
|
|
|
9 |
|
|
|
— |
|
|
|
62 |
|
Selling, general and administrative expenses |
|
|
6,425 |
|
|
|
9,016 |
|
|
|
13,196 |
|
|
|
17,110 |
|
Total operating expenses |
|
|
6,425 |
|
|
|
9,025 |
|
|
|
13,196 |
|
|
|
17,172 |
|
Loss from equity method investments |
|
|
(1,139 |
) |
|
|
(4,910 |
) |
|
|
(6,074 |
) |
|
|
(10,350 |
) |
Restructuring charges |
|
|
(401 |
) |
|
|
(314 |
) |
|
|
(684 |
) |
|
|
(2,094 |
) |
Loss from operations |
|
|
(9,597 |
) |
|
|
(13,623 |
) |
|
|
(21,452 |
) |
|
|
(28,299 |
) |
Interest income |
|
|
537 |
|
|
|
653 |
|
|
|
1,236 |
|
|
|
1,480 |
|
Interest expense |
|
|
(532 |
) |
|
|
(76 |
) |
|
|
(1,092 |
) |
|
|
(298 |
) |
Gain on derivative contracts |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Loss on sale of equity method investments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(13,886 |
) |
Other (loss) income |
|
|
(146 |
) |
|
|
(288 |
) |
|
|
(4,061 |
) |
|
|
965 |
|
Total other (expense) income |
|
|
(141 |
) |
|
|
289 |
|
|
|
(3,917 |
) |
|
|
(11,739 |
) |
Loss before income taxes |
|
|
(9,738 |
) |
|
|
(13,334 |
) |
|
|
(25,369 |
) |
|
|
(40,038 |
) |
Income tax benefit |
|
|
— |
|
|
|
(2 |
) |
|
|
— |
|
|
|
(3,095 |
) |
Net loss |
|
$ |
(9,738 |
) |
|
$ |
(13,332 |
) |
|
$ |
(25,369 |
) |
|
$ |
(36,943 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Basic and diluted: |
|
|
|
|
|
|
|
|
||||||||
Net loss per share |
|
$ |
(0.44 |
) |
|
$ |
(0.69 |
) |
|
$ |
(1.16 |
) |
|
$ |
(1.91 |
) |
Weighted-average shares outstanding |
|
|
21,945 |
|
|
|
19,370 |
|
|
|
21,942 |
|
|
|
19,348 |
|
|
|||||||
|
|
|
|
||||
Assets |
|
|
|
||||
Cash and cash equivalents |
$ |
56,074 |
|
|
$ |
87,840 |
|
Accounts receivable |
|
4,100 |
|
|
|
5,613 |
|
Other current assets |
|
5,155 |
|
|
|
9,186 |
|
Total current assets |
|
65,329 |
|
|
|
102,639 |
|
Property, plant and mine development, net |
|
135,722 |
|
|
|
134,544 |
|
Advances to affiliates |
|
41,990 |
|
|
|
39,548 |
|
Other non-current assets |
|
1,392 |
|
|
|
1,519 |
|
Equity method investments |
|
74,113 |
|
|
|
71,635 |
|
Total assets |
$ |
318,546 |
|
|
$ |
349,885 |
|
|
|
|
|
||||
Liabilities and Stockholders’ Equity |
|
|
|
||||
Accounts payable |
$ |
1,144 |
|
|
$ |
5,239 |
|
Accrued expenses |
|
2,670 |
|
|
|
4,313 |
|
Payables to affiliates |
|
5,131 |
|
|
|
6,719 |
|
Current debt obligations |
|
26,337 |
|
|
|
26,472 |
|
Other current liabilities |
|
833 |
|
|
|
3,363 |
|
Total current liabilities |
|
36,115 |
|
|
|
46,106 |
|
Long-term debt, net of current portion |
|
2,959 |
|
|
|
3,652 |
|
Operating lease liabilities, net of current portion |
|
769 |
|
|
|
863 |
|
Other non-current liabilities |
|
1,054 |
|
|
|
1,017 |
|
Total liabilities |
|
40,897 |
|
|
|
51,638 |
|
|
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Common stock; |
|
2 |
|
|
|
2 |
|
Additional paid-in capital |
|
499,226 |
|
|
|
497,878 |
|
Accumulated deficit |
|
(216,974 |
) |
|
|
(191,605 |
) |
Accumulated other comprehensive loss |
|
(4,605 |
) |
|
|
(8,028 |
) |
Total stockholders’ equity |
|
277,649 |
|
|
|
298,247 |
|
Total liabilities and stockholders’ equity |
$ |
318,546 |
|
|
$ |
349,885 |
|
|
|||||||
|
Six Months Ended
|
||||||
Cash flows from operating activities: |
|
2025 |
|
|
|
2024 |
|
Net loss |
$ |
(25,369 |
) |
|
$ |
(36,943 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
Stock-based compensation expense |
|
1,873 |
|
|
|
4,640 |
|
Loss from equity method investments |
|
6,074 |
|
|
|
10,350 |
|
Loss on sale of equity method investments |
|
— |
|
|
|
13,886 |
|
Loss (gain) on equity securities |
|
3,944 |
|
|
|
(1,594 |
) |
Deferred taxes |
|
— |
|
|
|
(6,246 |
) |
Depreciation and amortization |
|
119 |
|
|
|
156 |
|
Noncash lease expense |
|
85 |
|
|
|
532 |
|
Loss on sale of assets |
|
212 |
|
|
|
656 |
|
Unrealized foreign currency translation gains |
|
(318 |
) |
|
|
(36 |
) |
Changes in assets and liabilities: |
|
|
|
||||
Accounts receivable |
|
1,513 |
|
|
|
(12,725 |
) |
Other assets |
|
268 |
|
|
|
1,950 |
|
Operating lease liabilities |
|
(82 |
) |
|
|
(472 |
) |
Accounts payable |
|
(3,948 |
) |
|
|
(25 |
) |
Payables to affiliates |
|
(1,588 |
) |
|
|
(93 |
) |
Deferred revenue |
|
— |
|
|
|
24,347 |
|
Other liabilities and accrued expenses |
|
(4,111 |
) |
|
|
(27,164 |
) |
Net cash used in operating activities |
|
(21,328 |
) |
|
|
(28,781 |
) |
Cash flows from investing activities: |
|
|
|
||||
Capital expenditures |
|
(1,646 |
) |
|
|
(8,622 |
) |
Advances to affiliates |
|
(2,310 |
) |
|
|
(8,226 |
) |
Proceeds from sale of marketable securities |
|
— |
|
|
|
45 |
|
Proceeds from sale of shares in equity method investments |
|
— |
|
|
|
49,103 |
|
Additions to equity method investments |
|
(5,129 |
) |
|
|
(14,966 |
) |
Net cash (used in) provided by investing activities |
|
(9,085 |
) |
|
|
17,334 |
|
Cash flows from financing activities: |
|
|
|
||||
Proceeds from Credit Facility |
|
14,116 |
|
|
|
— |
|
Settlements of Credit Facility |
|
(14,116 |
) |
|
|
— |
|
Payments of debt obligations and insurance premiums financed |
|
(828 |
) |
|
|
(651 |
) |
Payments to tax authorities for employee stock-based compensation |
|
(525 |
) |
|
|
(654 |
) |
Net cash used in financing activities |
|
(1,353 |
) |
|
|
(1,305 |
) |
Net decrease in cash |
|
(31,766 |
) |
|
|
(12,752 |
) |
Cash and cash equivalents at beginning of period |
|
87,840 |
|
|
|
71,730 |
|
Cash and cash equivalents at end of period |
$ |
56,074 |
|
|
$ |
58,978 |
|
Non-GAAP Financial Measures
The following information provides definitions and reconciliations of certain non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. The non-GAAP financial measures presented do not have any standard meaning prescribed by GAAP and may differ from similarly-titled measures used by other companies. We believe that these adjusted measures provide meaningful information to assist management, investors, and analysts in understanding our financial condition and the results of operations. We believe these adjusted financial measures are important indicators of our recurring operations because they exclude items that may not be indicative of, or are unrelated to, our core operating results, and provide a better baseline for analyzing trends in our underlying businesses.
The following are non-GAAP financial measures for
Adjusted net (loss) income is defined as net (loss) income, as calculated under GAAP, plus or minus the gain or loss from sale of equity method investments, gain or loss on sale of assets, gain or loss from equity securities, gain or loss from foreign currency exchange, restructuring charges including severance and severance related costs and exit costs, and certain other adjustments we believe are not reflective of our ongoing operations and performance. These items include acquisition costs and other fees, and shelf registration costs.
Adjusted diluted earnings per share (or adjusted diluted EPS) is defined as diluted EPS, as calculated under GAAP, before gain or loss on sale of equity method investments, gain or loss on sale of assets, gain or loss from equity securities, gain or loss from foreign currency exchange, restructuring charges including severance and severance related costs and exit costs, and certain other costs we believe are not reflective of our ongoing operations and performance.
EBITDA is defined as net income (loss) before interest expenses, income tax expense, and depreciation.
Adjusted EBITDA is defined as EBITDA plus or minus the gain or loss on sale of equity method investments, gain or loss on sale of assets, gain or loss from equity securities, gain or loss from foreign currency exchange, restructuring charges including severance and severance related costs and exit costs, and certain other adjustments we believe are not reflective of our ongoing operations and performance.
Below are reconciliations of non-GAAP financial measures on a consolidated basis for adjusted net (loss) income, adjusted diluted EPS, EBITDA, and adjusted EBITDA.
Adjusted Net Loss and Adjusted Diluted EPS
|
|
Three Months Ended |
||||||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||||||
(in thousands, except per share amounts) |
|
|
|
Diluted
|
|
|
|
Diluted
|
|
|
|
Diluted
|
||||||||||||
Net loss |
|
$ |
(9,738 |
) |
|
$ |
(0.44 |
) |
|
$ |
(15,631 |
) |
|
$ |
(0.71 |
) |
|
$ |
(13,332 |
) |
|
$ |
(0.69 |
) |
Loss on sale of assets |
|
|
132 |
|
|
|
0.01 |
|
|
|
80 |
|
|
|
— |
|
|
|
656 |
|
|
|
0.03 |
|
Loss (gain) on equity securities(1) |
|
|
304 |
|
|
|
0.01 |
|
|
|
3,640 |
|
|
|
0.17 |
|
|
|
(210 |
) |
|
|
(0.01 |
) |
Loss from foreign currency exchange(2) |
|
|
(290 |
) |
|
|
(0.01 |
) |
|
|
195 |
|
|
|
0.01 |
|
|
|
(158 |
) |
|
|
(0.01 |
) |
Restructuring charges(3) |
|
|
401 |
|
|
|
0.02 |
|
|
|
283 |
|
|
|
0.01 |
|
|
|
314 |
|
|
|
0.02 |
|
Other costs(4) |
|
|
1,459 |
|
|
|
0.07 |
|
|
|
1,369 |
|
|
|
0.06 |
|
|
|
81 |
|
|
|
— |
|
Tax effect of adjustments(5) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2 |
) |
|
|
— |
|
Adjusted net loss |
|
$ |
(7,732 |
) |
|
$ |
(0.35 |
) |
|
$ |
(10,064 |
) |
|
$ |
(0.46 |
) |
|
$ |
(12,651 |
) |
|
$ |
(0.65 |
) |
______________________________________________________ | ||
(1) |
Loss (gain) on equity securities represents realized and unrealized gains on our equity security holdings in Atlantic Lithium and Ricca Resources. |
|
(2) |
Loss from foreign currency exchange primarily relates to currency fluctuations in our foreign bank accounts denominated in Canadian dollars and Australian dollars and marketable securities denominated in Australian dollars. |
|
(3) |
Restructuring charges relate to severance and reorganization related costs and exit costs related to our 2024 Cost Savings Plan. |
|
(4) |
Other costs include legal and transactional costs related to certain strategic transactions and shelf registration costs. |
|
(5) |
No income tax impacts have been given to any items that were recorded in jurisdictions with full valuation allowances. |
|
EBITDA and Adjusted EBITDA
|
Three Months Ended |
||||||||||
(in thousands) |
|
|
|
|
|
||||||
Net loss |
$ |
(9,738 |
) |
|
$ |
(15,631 |
) |
|
$ |
(13,332 |
) |
Interest income, net |
|
(5 |
) |
|
|
(139 |
) |
|
|
(577 |
) |
Income tax benefit |
|
— |
|
|
|
— |
|
|
|
(2 |
) |
Depreciation and amortization |
|
56 |
|
|
|
— |
|
|
|
75 |
|
EBITDA |
|
(9,687 |
) |
|
|
(15,707 |
) |
|
|
(13,836 |
) |
Loss on sale of assets |
|
132 |
|
|
|
80 |
|
|
|
656 |
|
Loss (gain) on equity securities(1) |
|
304 |
|
|
|
3,640 |
|
|
|
(210 |
) |
Loss from foreign currency exchange(2) |
|
(290 |
) |
|
|
195 |
|
|
|
(158 |
) |
Restructuring charges(3) |
|
401 |
|
|
|
283 |
|
|
|
314 |
|
Other costs(4) |
|
1,459 |
|
|
|
1,369 |
|
|
|
81 |
|
Adjusted EBITDA |
$ |
(7,681 |
) |
|
$ |
(10,140 |
) |
|
$ |
(13,153 |
) |
______________________________________________________ |
||
(1) |
Loss (gain) on equity securities represents realized and unrealized gains on our equity security holdings in Atlantic Lithium and Ricca Resources. |
|
(2) |
Loss from foreign currency exchange primarily relates to currency fluctuations in our foreign bank accounts denominated in Canadian dollars and Australian dollars and marketable securities denominated in Australian dollars. |
|
(3) |
Restructuring charges relate to severance and reorganization related costs and exit costs related to our 2024 Cost Savings Plan. |
|
(4) |
Other costs include legal and transactional costs related to certain strategic transactions and shelf registration costs. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250807436602/en/
Chief Financial Officer
T: +1 713 878 9049
E: mwhite@piedmontlithium.com
Investor Relations
T: +1 980 701 9928
E: jkoslow@piedmontlithium.com
Source: